Related Experiment Videos

Group B streptococcus during the perinatal period

R H Shermer1

  • 1Medical College of Virginia Hospitals, USA.

Insights

Group B Streptococcus (GBS) remains a significant threat to infants, causing maternal and neonatal morbidity. Staying updated on GBS prevention and treatment is crucial for perinatal nurses to improve patient care.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Group B Streptococcus (GBS) emerged as a significant pathogen in the 1960s.
  • GBS continues to be a primary cause of maternal and neonatal morbidity.
  • Rapid advancements necessitate updated knowledge for healthcare providers.

Purpose of the Study:

  • To highlight the ongoing threat of GBS to infants and mothers.
  • To emphasize the importance of current prevention and treatment strategies.
  • To underscore the need for perinatal nurses to stay informed.

Main Methods:

  • Review of GBS emergence and impact.
  • Analysis of current prevention strategies (chemoprophylaxis and immunoprophylaxis).
  • Emphasis on the rapid pace of research in GBS management.

Main Results:

  • GBS is a persistent leading cause of perinatal morbidity.
  • Prevention focuses on pathogen exposure reduction and host resistance enhancement.
  • Continuous learning is vital due to rapid research advancements.

Conclusions:

  • Perinatal nurses must remain current on GBS prevention and treatment.
  • Enhanced knowledge improves patient education and care outcomes.
  • Proactive engagement with research is essential for combating GBS.

Related Concept Videos